Skip to content
Brand AI

Serono

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2005

    Serostim off-label promotion and kickback allegations

    Serono agreed to pay $704 million to resolve civil and criminal allegations brought by the US Department of Justice. The allegations concerned a scheme to promote Serostim for off-label uses and provide illegal kickbacks related to prescribing, in violation of US healthcare-fraud laws.

    Source